“ProFound AI is revolutionizing the way mammography is read. With superior performance and sensitivity, the software offers unrivaled accuracy and time-savings benefits,” according to Stacey Stevens, President of iCAD, the manufacturer of ProFound AI. “As one of the latest tools in the fight against breast cancer, we are pleased that it will soon be available to more women in New Jersey.”
ProFound AI for DBT was clinically proven in a large reader study to increase radiologists’ sensitivity by 8 percent, minimize the rate of false positives and unnecessary recalls by 7 percent and reduce reading time by 52.7 percent.i ProFound AI was also clinically proven to slash reading time by up to 57.4 percent for radiologists reading cases of women with dense breasts.ii
“When ProFound AI highlights an area, we know it’s something to investigate. It’s much more selective than other CAD technologies and offers a remarkable improvement in terms of the focus,” says Dr. Sheppard. She adds, “This technology has made a tremendous impact on patient care at PINK Breast Center. It helps to ensure that the biopsies we perform are more likely to be cancer, and we also now have fewer false positives and callbacks.”
About ImageCare Centers
ImageCare Centers is committed to providing the most advanced medical diagnostic imaging to their patients, so they are comfortable and at ease. With their caring and compassionate staff, and team of skilled radiologists, they offer a wide array of State-of the-Art Radiology services including Open and Closed MRIs, Sedation MRIs, CT scans, Ultrasounds, X-rays, DEXA Bone Density Scans, 3D Mammograms with Artificial Intelligence, Pediatric Radiology and PET/CT scans. ImageCare has centers conveniently located throughout North and Central New Jersey in Bergen, Essex, Hunterdon, Middlesex, Monmouth, Morris, Passaic, Sussex, and Warren Counties.
About iCAD, Inc.
Headquartered in Nashua, NH, USA, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions.
Back to HCB News
